Regeneron Pharmaceuticals as of November 14, 2025 · AsOf
Viewing the record as of . Facts, events and changes are as the record holds them for that day. Back to today
organization
Regeneron Pharmaceuticals
As of , Regeneron Pharmaceuticals was an American pharmaceutical company, headquartered in Tarrytown and founded in . Its CEO was Leonard S. Schleifer, since . It reported revenue of $14.20B for the period ended .
Models, products and related entities are not dated to , so they are left out here. They are on today’s record.
State as of
10 assertedThe record stands behind this value for the day asked: two independent sources agree, or a primary source states it (alone, at confidence 0.7 or more). Everything else stays on the record, labelled.More in About → facts
Regeneron Pharmaceuticals: state as of 2025-11-14, one row per fact with its value, date, confidence and sources
fact
value
valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →
confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →
sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →
As reported in the linked filings, which may be restated. Not investment advice.
State changes since
21 changes · supersededA later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.More in About →
· quarterly operating incomequarterly operating income